Epigenetic mechanisms, trauma, and psychopathology: Targeting chromatin remodeling complexes by Bielawski T. et al.
Rev. Neurosci. 2019; 30(6): 595–604
Tomasz Bielawski*, Blazej Misiak, Ahmed Moustafa and Dorota Frydecka
Epigenetic mechanisms, trauma, and 
psychopathology: targeting chromatin remodeling 
complexes
https://doi.org/10.1515/revneuro-2018-0055
Received June 4, 2018; accepted October 19, 2018; previously 
 published online February 7, 2019
Abstract: Environmental pressure affects the genotype 
throughout different epigenetic processes. There is cur-
rently ample evidence on the role of epigenetics in develop-
ing various mental disorders. A burden of environmental 
pressure, such as psychological trauma, and its influence 
on genotype can lead to a variety of psychopathologies. 
Thus, this study focuses on the epigenetic activity of the 
complex protein machinery operating on chromatin – 
the ATP-dependent chromatin remodeling complexes. 
Although there are several recent studies on the molecu-
lar structure, functions, and taxonomy of ATP-dependent 
chromatin remodeling complexes, the focus of this paper is 
to highlight the importance of those ‘protein machines’ in 
developing psychiatric disorders. Data were obtained from 
human preclinical and clinical studies. The results of this 
review indicate an importance of ATP-dependent chroma-
tin remodeling complexes in the interaction between envi-
ronmental factors, including traumatic events, and genetic 
vulnerability to stress. Several studies indicate that ATP-
dependent chromatin remodeling complexes play a crucial 
role in the development and consolidation of memory, in 
neurodevelopmental processes, and in etiology depres-
sive-like behavior. Thus, the activity of those ‘protein 
machines’ emerges as a key factor in the pathophysiology 
of various psychiatric diseases. It can also be concluded 
that the limitations of clinical studies may be explained by 
inappropriate laboratory methods and research paradigms 
due to the delayed timeframe of biochemical responses to 
environmental stimuli. Future research in this field may 
enable a better understanding of the pathophysiology of 
psychiatric diseases and contribute to the development of 
novel molecular treatment targets.
Keywords: ATP-dependent chromatin remodeling 
complex; epigenetics; psychiatry; psychopathology; 
trauma.
Introduction
There is a growing body of evidence that epigenetic pro-
cesses play an important role in the development of psy-
chopathologies. Historically, epigenetics was defined as 
an interaction between different molecular pathways, 
which determines the phenotype under the influence of 
the environment (Waddington, 1968). However, Jullien 
and Berger (2009) defined epigenetics as follows: ‘An epi-
genetic trait is a stably heritable phenotype resulting from 
changes in a chromosome without alterations in the DNA 
sequence’. The following processes have been recognized 
as epigenetic mechanisms: DNA methylation, modifica-
tion of histones (e.g. methylation, acetylation, and phos-
phorylation), regulation of DNA expression by microRNA 
species, and modification via ATP-dependent protein 
complexes. The effects of these mechanisms as well as the 
regulatory enzymes involved in biochemical pathways are 
key epigenetic processes (Ptashne, 2007; Tsankova et al., 
2007). Over the past few years, the role played by epige-
netic processes in the development of psychiatric disor-
ders became widely accepted. Throughout the human life, 
the environment puts pressure on individual genotype, 
initiating various epigenetic mechanisms. One such clini-
cally important environmental pressure is psychological 
trauma. Recent reports lend support to the considerable 
impact of traumatic events on epigenetic processes, which 
contribute to the development of psychopathologies (Sun 
et al., 2015; Misiak et al., 2017). By targeting epigenetics in 
psychiatry research, several studies have focused on DNA 
methylation and histone acetylation (Table 1), yet nucleo-
some remodeling via ATP-dependent complexes in devel-
oping psychopathologies remains an unexplored area. 
These protein complexes control the histone arrangement 
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and thereby alter the chromatin structure (Vignali et  al., 
2000). A tightly packed heterochromatin is unavailable 
to translation, contrary to a loose form of euchroma-
tin, which enables the initiation of translation because 
of easy access to genes located within. ATP-dependent 
complexes use ATP hydrolysis to steer a dynamic process 
of DNA accessibility. Thus, they are pivotal for adequate 
temporal and spatial gene expression (Zaghlool et  al., 
2016). ATP-dependent complexes can be grouped accord-
ing to a unique ‘taxonomy’ that refers to the specificity 
of distinct ATPase subunits (Vignali et  al., 2000; Becker 
and Hörz, 2002). Indeed, four groups of ATP-dependent 
complexes, including switch/sucrose non-fermentable 
(SWI/SNF), imitation switch (ISWI), chromodomain heli-
case DNA-binding (CHD), and inositol (INO80), play a 
role in genomic homeostasis during the lifespan (Zaghl-
ool et  al., 2016). Every complex is a ‘protein machinery’ 
built around ATPase, with many multifunctional protein 
subunits. The INO80 group is important for DNA repair, 
checkpoint regulation, DNA replication, telomere mainte-
nance, and chromosome segregation (Morrison and Shen, 
2009). Although INO80 is crucial for many processes 
involved in developmental processes and homeostasis, its 
impact on human neurobiology is either minor or not yet 
known. For this reason, this paper focuses on two protein 
families – the SWI/SNF and ISWI complexes. The protein 
family CHD is included in this review only in reference to 
the increased number of reports, suggesting the involve-
ment of CHD proteins in the etiology of autism spectrum 
disorder (ASD). The aim of this review paper is to both (a) 
provide basic and initial information about selected epige-
netic ‘complex protein machines’ operating on chromatin 
– ATP-dependent chromatin remodeling complexes – and 
(b) highlight the relationship between traumatic stress and 
those proteins. A detailed description of the molecular and 
physicochemical properties of ATP-dependent chromatin 
remodeling complexes is beyond the scope of this article.
Materials and methods
To conduct our search, we have used the following data-
bases: PubMed, Scopus, Medline, Google Scholar, and 
Web of Science, using the following keywords: ‘epigenetic’, 
‘trauma’, ‘chromatin remodeling complexes’, ‘psychopathol-
ogy’, ‘SWI’, ‘SNF’, ‘ISWI’, ‘ATP dependent chromatin remod-
eling complexes’, ‘CSDS’, ‘chronic social defeat stress’, 
‘psychopathology’, ‘autism’, ‘schizophrenia’, ‘bipolar dis-
order’, ‘depression’, and ‘BAF’. Keywords were used in 
various combinations to find articles regarding the role of 
ATP-dependent chromatin remodeling complexes in the 
development of various psychopathologies. Furthermore, 
the references section of the publications we found based 
on the criteria described above was manually reviewed for 
relevant articles. The following publication records were 
included: (1) publications in English, (2) publications from 
peer-reviewed journals or books, and (3) review articles 
or original studies of human subjects or animal models, 
 presenting data of clinical/psychiatric importance.
Results
After conducting the preliminary search with defined 
 keywords as mentioned above, we obtained 65 articles on 
Table 1: Selected papers targeting epigenetic processes other than ATP-dependent chromatin remodeling complexes.
Epigenetic process Title Authors
Methylation Balancing histone methylation activities in psychiatric disorders Peter and Akbarian, 2011
DNA methylation and antipsychotic treatment mechanisms in schizophrenia: 
Progress and future directions
Ovenden et al., 2018
DNA methylation in schizophrenia Pries et al., 2017
Increased serotonin transporter gene (SERT) DNA methylation is associated 
with bullying victimization and blunted cortisol response to stress in 
childhood: a longitudinal study of discordant monozygotic twins
Ouellet-Morin et al., 2013
The role of DNA methylation in the central nervous system and 
neuropsychiatric disorders
Feng and Fan, 2009
Recently evolved human-specific methylated regions are enriched in 
schizophrenia signals
Banerjee et al., 2018
Acetylation Exercise-induced modulation of histone H4 acetylation status and cytokines 
levels in patients with schizophrenia
Lavratti et al., 2017
Chemogenomic analysis reveals key role for lysine acetylation in regulating Arc 
stability
Lalonde et al., 2017
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the given topic. We excluded six of these articles based 
on the following exclusion criteria: (1) articles concern-
ing strictly molecular structure and/or physicochemi-
cal properties of ATP-dependent chromatin remodeling 
complexes, (2) articles concerning the function of ATP-
dependent chromatin remodeling complexes outside the 
nervous system, and (3) articles concerning the role of epi-
genetic mechanisms other than ATP-dependent chroma-
tin remodeling complexes in the development of mental 
disorders. A total number of 59 articles were included in 
this review; 31 of them were experimental studies.
SWI/SNF family
A complex taxonomy of SWI/SNF chromatin remodeling 
complexes is based on the conserved ATPase subunit that 
represents the SWI2/SNF2 protein family. In humans, 
the most common ATPase subunits are hBRM and BRG1 
(Vignali et  al., 2000; Becker and Hörz, 2002). A compli-
cated machinery of different protein subunits is formed 
around the ATPase subunit (Table 2). One of those pro-
teins are the BRG1 or HBRM-associated factors (BAF) com-
plexes. The mutations of the polymorphic BAF complexes 
are often associated with altered cognitive functions. 
Notably, BAF complexes are expressed by postmitotic 
neurons [known as neuronal BRG1 or HBRM-associated 
factors (nBAF)]. Mutations in the neuron-specific subunit 
known as BAF53b (actin-related protein) result in long-
term memory deficits and altered hippocampal synaptic 
plasticity (Vogel-Ciernia et  al., 2013). Transgenic mice 
with a deletion of the hydrophobic domain of BAF53b 
perform significantly worse than healthy control mice on 
the Object Location Memory Test (OLM) and Object Rec-
ognition Memory Test (ORM) as well as in a long-term 
memory version of both tests. In the short-term memory 
versions of OLM and ORM, mutants did not differ signifi-
cantly from wild-type (control) individuals. Similar results 
were obtained in fear conditioning tasks in the lateral 
amygdala neurons (Yoo et al., 2017). Genetic manipulation 
in the BAF53b subunit results in an altered gene expres-
sion and leads to an impairment of hippocampal synaptic 
plasticity (Vogel-Ciernia et  al., 2013) and a blunted den-
dritic outgrowth in the hippocampus (Wu and Liu, 2007). 
The overexpression of BAF53b does not enhance the 
already existing memory but plays a crucial role in con-
solidating and forming a memory trail. BAF53b operates 
in a late phase of memory creation (after up to 24 h after 
training) and plays an essential role in creating long-term 
memory as found in the paradigm of fear conditioning 
(Yoo et al., 2017). Important recent reports by Marom et al. 
(2017) confirm the key role of the BAF complex in develop-
ing intact cognitive functioning. A pathogenic variant of 
the actin-like 6A (ACTL6A) gene (which encodes another 
protein component of the BAF complex) was described 
in three subjects with developmental disabilities, affect-
ing mainly language and memory (Marom et  al., 2017). 
Although the size of a group does not allow us to draw 
unequivocal conclusions, this report is part of a series of 
studies confirming the relevance of ATP-dependent com-
plexes and their genetic impact on cognitive functions. 
Altered hippocampal cytoarchitecture, especially among 
dendrites, is also observed during the manipulation in 
other components of BAF, especially the SWI/SNF-related, 
matrix-associated, actin-dependent regulator chromatin A2 
(SMARCA2) gene. Some polymorphisms of the SMARCA2 
gene are linked to the animal model of schizophrenia (Loe-
Mie et al., 2010) and human schizophrenia (Walsh et al., 
2008), whereas mutations in SMARCA2 are linked to the 
Coffin-Siris syndrome (Santen et al., 2012; Tsurusaki et al., 
2012), Nicolaides-Baraitser syndrome (Van Houdt et  al., 
2012), and general intellectual disability (Hoyer et  al., 
2012). In addition, SMARCA2 (and its protein product) 
seems to be one of the ‘network centers’ among the SWI/
SNF (BAF) complexes. The SMARCA2 gene is modified 
by the down-regulation of REST/RFSF, which results in 
alterations of other interactors and consequences in the 
development of abnormal dendritic spines. Mouse models 
revealed impaired social interaction and prepulse inhibi-
tion in Smarca2 knockout mice. Importantly, deficits in 
both domains – social interaction and prepulse inhibi-
tion – are observed in patients with schizophrenia. More-
over, it is possible to manipulate the expression of the 
SMARCA2 gene by the application of psychoactive drugs 
that down-regulate this complex and antipsychotic drugs 
that in turn up-regulate it. Therefore, SMARCA2 is con-
sidered to be involved in the pathophysiology of schizo-
phrenia (Koga et al., 2009; Loe-Mie et al., 2010). Several 
mutations in the SMARCA2 gene seem to be related to the 
Coffin-Siris syndrome, which is characterized by intel-
lectual disability, growth deficiency, microcephaly, and 
Table 2: Few of many genes and protein units/subunits of the  
SWI/SNF group ATP-dependent chromatin remodeling complexes.
Examples of genes involved 
in coding units and subunits




ACTL6A   BAF   BRG1
ACTL6A   BAF53a   BRG1
SMARCA2   nBAF   hBRM
SMARCA2   BAF53b   hBRM
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a number of dysmorphic features (Tsurusaki et al., 2012). 
Loe-Mie et  al. (2010) revealed how these schizophrenia-
related genes, and their protein products, are evolutionary 
novel. Risk alleles in the SMARCA2 gene are derived from 
a point mutation in the conservative region. This muta-
tion leads to altered protein trafficking in the cytoplasm-
nucleus pathway. This mechanism is hypothesized to 
influence both robust primate evolution and schizophre-
nia. Finally, there is a positive selection among primates 
and humans toward the SMARCA2 risk alleles, which rein-
force the appearance of this evolutionally novel molecular 
phenomena (Loe-Mie et al., 2010).
Epigenetic mechanisms regulated by ATP-depend-
ent chromatin remodeling structures within the SWI/
SNF family are being affected by other ongoing epige-
netic processes or even occur in coordination with other 
chromatin remodeling complexes (Zaghlool et al., 2016). 
Gozes (2016) suggested that there is a possible interac-
tion between activity-dependent neuroprotective protein 
(ADNP) and the SWI/SNF complexes. An increased activ-
ity of ADNP (at the mRNA and protein level) has been 
reported in peripheral blood lymphocytes of patients 
with schizophrenia as well as in individuals with mild 
cognitive impairment (Gozes, 2016). The ADNP level has 
been associated with cognitive functions in patients with 
Alzheimer’s disease (Magen and Gozes, 2014) and cor-
relates with the level of τ protein in an animal model of 
Alzheimer’s disease (Schirer et  al., 2014). The altered 
interaction between ADNP and SWI/SNF is proposed as 
one of the potential indicators of ASD (Vandeweyer et al., 
2014). Helsmoortel et al. (2014) showed that mutations in 
the ADNP gene occur in at least 0.17% of patients with 
ASD. This estimation may seem irrelevant, but in fact it is 
among the most prevalent ASD genes, taking into account 
the fact that no single gene is found to be mutated in more 
than 1% of patients with autism (Vandeweyer et al., 2014). 
These findings provide evidence of complex protein-pro-
tein and multigene interactions that could be a conse-
quence of epigenetic mechanisms. A biochemical analysis 
performed by Mandel et al. (2008) revealed that proteins 
form the SWI/SNF chromatin remodeling complex family 
(BRG1, BAF250a, and BAF170) immunoprecipitated with 
ADNP. Furthermore, ADNP binds to SMARCA2, SMARCA4, 
and SMARCC2 by its C-terminal end and possibly posi-
tions the whole protein complex in the appropriate DNA 
location by its zinc finger and homeobox domain. This 
crucial relationship explains the impact of epigenetic 
processes, involving nBAF complexes and concomitant 
enzymes on altered cognitive abilities, intellectual dis-
abilities, and ASD. A specific protein architecture among 
nBAF complexes regulates the functional characteristics 
and tissue specificity during neuronal development. 
Location shift of 3 of 15 subunits of BAF components initi-
ate dendritic outgrowth and axonal development. Thus, 
mutations of the nBAF protein components (SAMRCB1, 
SMARCA4, SMARCA2, SMARCE1, ARID1A, and ARID1B) 
are reported in syndromic intellectual disability disorders 
(Santen et al., 2012; Vandeweyer et al., 2014). To date, the 
reports of exome sequencing analyses of patients with 
ASD reveal even more important mutations in genes 
encoding the nBAF proteins, including BAF155, BAF170, 
BAF180, BAF250b, and BAF100a (O’Roak et  al., 2012; 
Basak et al., 2015).
ISWI family
A complex taxonomy of the ISWI chromatin remodeling 
complexes is based on the conserved ATPase subunit that 
belongs to the ISWI protein family. In humans, the most 
common ATPase subunit is SMARCA5 (hSNF2h; Vignali 
et al., 2000; Becker and Hörz, 2002). A complex machin-
ery of protein is formed around the ATPase subunit. The 
most widely studied protein complex is ATP-utilizing 
chromatin assembly and remodeling factors (ACF) and its 
subunit bromodomain adjacent to zinc finger domain 1A 
(BAZ1A; Table 3). Animal models imply an overexpression 
of the ACF (and BAZ1A) gene in the nucleus accumbens 
(NAc), which results in greater reductions of social inter-
action and lower sucrose preference. As much as 65% of 
experimental mice with up-regulated ACF exhibit depres-
sion-related behavioral abnormalities, including social 
avoidance. The up-regulation of BAZ1A correlates with 
a greater susceptibility to social defeat stress in animal 
models (Sun et  al., 2015). This leads to a disruption in 
nucleosome location and gene silencing (Sananbenesi 
and Fischer, 2009). The chronic social defeat stress (CSDS) 
experiment demonstrates the importance and impact 
of epigenetic processes on the development of patho-
logical behavior (Golden et al., 2011; Sun et al., 2015). It 
is undeniable that some individuals are characterized by 
genetic vulnerability to develop depression-like behavior. 
However, this genetic background is not sufficient; thus, 
Table 3: Gene and subunit of the ISWI group AlP-dependent 
chromatin remodeling complexes.
Example of gene involved in 
coding units and subunits
  Protein 
subunit
  ISWI ATPase 
unit
BAZ1A   ACF   SMARCA5
T. Bielawski et al.: Epigenetic mechanisms, trauma, and psychopathology      599
an interaction with disadvantageous environment is obvi-
ously required for the development of depression (e.g. 
mice placed in a cage with dominant and an aggressive 
individuals with high position in the hierarchy). In this 
experimental paradigm, epigenetic changes are observed, 
which includes upstream regulation of the ISWI family 
subunit (BAZ1A), likely due to altered ventral tegmental 
area neuronal projections to NAc as well as the activation 
of the BDNF protein (Sun et al., 2015). In the NAc, BAZ1A 
alters the activity of chromatin remodeling complexes. 
ATP-dependent ‘protein machinery’ is more likely to 
position nucleosomes within the transcription start sites 
(TSS regions), blocking translation and silencing genes 
(Sananbenesi and Fischer, 2009). Therefore, depressive-
like behavior can be observed not due to the activation 
of some defective or mutated genes but due to epigenetic 
alterations of ATP-dependent chromatin remodeling com-
plexes (Figure 1).
The BAZ1B protein, with a similar structure to BAZ1A, 
works contradictory to BAZ1A and heightens responses to 
rewarding stimuli as well as promotes adaptive responses 
to aversive stimuli. BAZ1B appears to be closely related 
to chronic salient stimuli: cocaine administration and 
CSDS. Importantly, behavioral effects caused by cocaine 
and CSDS last longer than remodeled chromatin complex. 
BAZ1B levels return to control values within hours after 
cocaine administration or stress exposure, whereas 
behavioral repercussions of these treatments can be still 
observed for a long time afterward. Thus, it is hypoth-
esized that epigenetic changes in chromatin induce 
further alterations in various genes, which exert longer 
behavioral effects (Sun et al., 2015). BAZ1A contribute to 
stress susceptibility maintenance of depressive-like phe-
notypes, whereas BAZ1B promotes adaptive responses to 
aversive stimuli, being hypothesized to serve as a stress 
resilience indicator. Other studies have revealed an inter-
action between the ACF (ISWI family) and BAF (SWI/SFN) 
components, particularly between BAZ1B and SMACRA 
genes, which can have clinical implications for future 
studies (Zaghlool et al., 2016). BAZ1B plays a pivotal role 
in neuron differentiation from pluripotent stem cells. 
Moreover, the haploinsufficiency of the BAZ1B gene plays 
a crucial role in the development of Williams syndrome 
(Lalli et al., 2016).
CHD family
In the CHD family, SNF2-like ATPase domain is located in 
the center of a protein network and the tandem chromo-
domains are located in the N-terminal region (Marfella 
and Imbalzano, 2007). There are several human diseases 
associated with the CHD protein family (e.g. dermato-
myositis, Hodgkin’s lymphoma, neuroblastoma, and the 
CHARGE syndrome) and some reports suggest that it has 
an anticancer properties (Rother and van Attikum, 2017), 
but due to the scope of this article we focus on the CHD8 
gene, which is strongly associated with ASD. This gene 
encodes a protein with the ATP-dependent chromatin 
remodeling activity. CHD8 binds to posttranslationally 
trimethylated histone H3 at active promoters and modu-
lates the interaction between DNA and histone (Thomp-
son et al., 2008; Cotney et al., 2015). Krumm et al. (2014) 
revealed that CHD8 represents genes with de novo loss-of-
function mutations in large-scale resequencing studies of 
ASD. Combined with reports of the CHD8 role in the neu-
rodevelopment of midfetal cortex, these findings suggest 
an important role of the CHD protein family in the devel-
opment of cognitive impairments. Other research has 
confirmed that CHD8 activity targets risk genes for ASD. 
Indeed, a loss of the CHD8 gene significantly deregulates 
the function of ASD-related genes (Cotney et al., 2015). An 
important role of CHD8 in genomic homeostasis during 
neurodevelopment, along with reports on BAF protein 
and the ADNP enzymatic role (discussed in the ‘SWI/
SNF family’ section), implies that understanding and 
Figure 1: Euchromatin (A) changes to heterochromatin (B) in NAc.
ATP-dependent chromatin remodeling complexes position 
nucleosomes close to the TSS region (B) and therefore unable 
transcription. In an animal model of CSDS, Sun et al. (2015) showed 
that such a phenomenon occurs more often among individuals 
susceptible to CSDS, and it leads to development depression-like 
phenotype.
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explaining the pathophysiology of ASD might be achieved 
using epigenetic approaches.
Memory of psychological trauma and ATP-
dependent chromatin remodeling complexes
The definition of epigenetic processes emphasizes its 
crucial role in the mediation between environmental 
pressure and genotype (Waddington, 1968; Ptashne, 
2007). Stressful and traumatic events, as part of envi-
ronmental burden, have large impact on the develop-
ment of the phenotype, somatic and mental health state, 
psychosocial functioning, and general environmental 
fitness (Weiner, 1992). Clinical studies reveal a number of 
posttranslational alterations in protein architecture that 
result in signaling cascade forming short-term memory. 
Then, epigenetic processes contribute to the conversion of 
unstable short-term memory to robust long-term memory 
trail. Thus, new gene expression is hypothesized to be 
crucial in creating long-lasting memory trail of a stress-
ful event (Barrett and Wood, 2008; Kwapis and Wood, 
2014). Animal studies of memory consolidation often use 
trauma paradigm or fear conditioning due to the neces-
sity of strong stimulus appliance. There are several lines 
of evidence revealing how various traumatic events affect 
epigenetic processes, mainly due to histone acetylation, 
histone phosphorylation, and methylation, but there are 
also reports about DNA methylation and nucleosome 
remodeling complexes (Vogel-Ciernia et al., 2013; Kwapis 
and Wood, 2014; Sun et al., 2015). Epigenetic mechanisms 
of ATP-dependent chromatin remodeling complexes take 
part in memory consolidation through the nBAF complex 
and its BAF53b subunit. Although BAF53b seems to be 
pivotal for the consolidation of, particularly, visually con-
textual fear memory, it does not participate in the con-
solidation of auditory fear (Kwapis and Wood, 2014). The 
nBAF complexes play a crucial role in the consolidation 
of the hippocampus-related memory trails, whereas audi-
tory amygdala-dependent trails are autonomous from the 
BAF53b complex. In animal studies, the CSDS paradigm 
is used to develop depressive-like features, manifesting 
in anxiety, anhedonia, and social avoidance in rodents 
(Golden et  al., 2011). Considering the CSDS protocol, 
results obtained with this paradigm can easily be catego-
rized as consequences of an exposure to trauma. In this 
protocol, a smaller mouse is placed in a cage with a bigger 
and more aggressive male. Interindividual interference 
that lasts for 5–10 min is pivotal for the protocol because, 
after the defeat of the smaller mouse, both rodents are 
separated by Plexiglass, allowing visual and olfactory, 
but not physical, contact for the following 24  h. The 
procedure is repeated for 10 consecutive days, each day 
with a different aggressor (Golden et al., 2011; Sun et al., 
2015). The CSDS procedure attunes with modern trauma 
definitions that imply the occurrence of various types of 
traumatic events (Sideli et al., 2012; Misiak et al., 2017). 
Another important factor is interindividual interference 
(presenting in abuse, neglect, wars, human-made dis-
aster, technological disasters, or assaults), considering 
there is a lower prevalence of posttraumatic stress dis-
order as an aftermath of natural disasters (Galea et  al., 
2005; Neria et  al., 2008). Thus, taking into account all 
the variables discussed above, we here provide a crucial 
information about molecular alterations emerging after 
trauma. In animal models, applying the CSDS paradigm 
results in alterations among all four families of the ATP-
dependent protein complexes (SWI/SNF, ISWI, CHD, and 
INO80) in the NAc. Particularly robust up-regulation of 
the BAZ1A protein was observed among stress-suscep-
tible individuals, and the interaction between BAZ1A 
and SMARCA5 genes in executing transcriptional regu-
lations was noted. Interestingly, the up-regulation of 
BAZ1A mRNA is observed in the NAc in postmortem brain 
examinations in individuals with depression (Sun et al., 
2015). This allows us to hypothesize similar epigenetic 
mechanisms among CSDS-susceptible people and animal 
(rodent) models. Moreover, a significant up-regulation 
in the prefrontal cortex of BAZ1A genes was observed 
in genome-wide expression profiling of schizophrenia 
patients performed by Mistry et al. (2013). This is in agree-
ment with several studies showing an increased risk of 
psychosis in individuals with a history of childhood 
trauma (Varese et al., 2012). In addition, novel theoreti-
cal models consider childhood trauma (and concomitant 
epigenetic alterations) to be essential components of the 
etiology of psychosis (Misiak et al., 2017). Early-life adver-
sities cause significant alterations in NAc activity (Tidey 
and Miczek, 1996; Gambarana et al., 2001; Salamone and 
Correa, 2012), which is a structure of great dependency 
from the ATP-dependent chromatin remodeling com-
plexes (Sun et al., 2015).
Discussion
Epigenetic processes may not be a primary cause of 
psychiatric diseases, but their alterations can have an 
important downstream effect on mental health. Recent 
reports suggest a presence of an interrelation between 
chromatin remodeling complexes and even alcohol 
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dependence. Animal studies of the nematode Caeno-
rhabditis elegans reveal a relationship between the 
SWI/SNF chromatin remodeling complexes and acute 
behavioral response to ethanol (Mathies et  al., 2015). 
The results are significant for human studies mainly due 
to a similar and conservative molecular mechanism in 
mammals and worms. This relationship can be observed 
in clinical research, where an association among ATP-
dependent chromatin remodeling complexes, antiso-
cial behavior, and alcohol dependence has been shown 
(Mathies et  al., 2015). It is highly plausible that ATP-
dependent chromatin remodeling complexes assist in 
many neural processes and possibly even play a crucial 
role in the development of pathological mechanisms, but 
they are difficult to examine due to their subtle and inter-
mediary functions. A mediation on the molecular level 
between environmental stimuli and an adequate genetic 
response is difficult to be investigated mainly because 
our methods and research paradigms may not be appro-
priate. Yoo et al., 2017 showed that ATP complexes that 
are pivotal in consolidating memory trials can peak up to 
24 h after stimulation. If other ATP-dependent chroma-
tin remodeling complexes work in a similar manner, we 
have to change our testing paradigms and stop looking 
for direct and rapid stimulus-based effects. The complex-
ity of multiprotein constructions, diversity in subunit 
functions, and family ‘taxonomy’, along with a complex 
cooperation between various ATP-dependent chromatin 
remodelers, dims overall the picture of what we know 
about those molecules. Some studies (Larrieu et  al., 
2017) provide important reports about the neurochemi-
cal modifications and metabolic alterations in distinct 
brain regions, such as the NAc, which is known for being 
widely regulated by ATP-dependent chromatin remod-
elers (Sun et al., 2015). Extending our knowledge about 
epigenetic processes may contribute to explain these 
discrepancies. Novel theoretical models on the develop-
ment of psychosis among people with childhood trauma 
emphasize the importance of environmental factors 
in developing psychopathology (Misiak et  al., 2017). It 
seems inevitable that epigenetic mechanisms, such as 
chromatin remodeling complexes, play a pivotal role 
in the interdependence between environmental factors 
(like trauma) and genetic vulnerability, further leading 
to biological alterations that result in pathological and 
psychological mechanisms and psychiatric diseases. 
ATP-dependent chromatin remodeling complexes may 
predetermine mental disorders and constitute trigger-
ing factors for psychiatric diseases. Furthermore, epige-
netic alterations of genes involved in the regulation of 
ATP-dependent chromatin remodeling complexes and 
schizophrenia pathophysiology are observed in our 
ancestral, phylogenetic tree. This validates the relevance 
and utility of psychiatric animal model studies. It is 
not difficult to hypothesize about the potential clinical 
importance of more robust research in this area. Exam-
ples of translating epigenetic mechanisms into clinical 
trials can be found in some diseases associated with neu-
rodegeneration, such as Huntington’s disease. Although 
it is a hereditary and fatal disorder caused by dynamic 
mutations, epigenetic modifications are critical in the 
development of Huntington’s disease. Promising drugs 
that are being investigated in preclinical studies inhibit 
neurodegeneration in Huntington’s disease via modifica-
tions of chromatin (Kim and Kaang, 2017). The majority 
of mental disorders cannot be described as monogenic 
phenotypes and one disease approach. The ‘multiprotein 
machinery’ of ATP-dependent chromatin remodeling 
complexes, alongside different regulatory enzymes, is 
involved in complex protein-protein networks and mul-
tigene systems. Improving our knowledge in this field 
may be challenging, but the complexity of environmen-
tal factors and genetic vulnerability creates a vast range 
of methods for both the prevention and management 
of various psychopathologies. Recent reports of epige-
netic mechanisms, other than ATP-dependent chromatin 
remodeling complexes (like histone or DNA methyla-
tion and histone modifications), imply that substantial 
molecular changes can be induced by various lifestyle 
factors. Changes in the physical activity of schizophre-
nia patients may induce hypoacetylation of histone 4 
as well as down-regulation of inflammatory processes 
in the peripheral blood (Lavratti et  al., 2017). Another 
important relationship was pointed out by Alam et  al. 
(2017), who highlighted the relationship among diet, 
gut microbiota, and different epigenetic processes (like 
DNA methylation), with relevance to mental disorders 
(Malan-Muller et al., 2018). It can be hypothesized that 
similar, yet undiscovered, relationships between life-
style-dependent environmental factors and significant 
molecular alterations may be induced by epigenetic 
mechanisms related to ATP-dependent chromatin remod-
eling complexes. It seems evident that we are facing an 
uncharted field, where the association between environ-
mental stress and genetic adaptation can be observed at 
the molecular level in vivo. Some authors hypothesized 
epigenetics to carry the potential of transgenerational 
inheritance (Woodhouse, 2018; Yeshurun and and 
Hannan, 2018). It is possible that we are yet to discover 
a whole new ‘layer’ of  mechanisms that not only simply 
control gene expression but also serve as potential treat-
ment and diagnostic targets.
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Main findings
Our review of the current literature provides a framework 
to better understand the role of epigenetic mechanisms 
of ATP-dependent chromatin remodeling complexes in 
developing psychopathologies. Environmental pressure, 
manifesting in various forms, via epigenetic processes, 
interacts with genetic vulnerability and plays an impor-
tant role in the development of psychiatric disorders. 
‘The protein machinery’ of ATP-dependent chromatin 
remodeling complexes, as well as different accompany-
ing enzymes, steers a dynamic process of DNA accessibil-
ity, up-regulate and down-regulate gene expression, and 
affect neuronal development. Three ‘families’ of proteins 
– SWI/SNF, ISWI, and CHAD, representing ATP-depend-
ent chromatin remodeling complexes – play a crucial role 
in the development of various psychopathologies that 
are often accompanied by cognitive impairment. In this 
article, we reviewed the role of ATP-dependent chroma-
tin remodeling complexes in forming long-term memory 
trails and attuned these findings to modern models of psy-
chological trauma. We reasoned that psychological phe-
nomena, including helplessness, forced submission, and 
low in-hierarchy position, lead to epigenetic changes. We 
showed evidence of the crucial role of chromatin remod-
eling complexes in the development of depressive-like 
behavior in the social defeat paradigm. We also provided 
potential limitations of laboratory methods (examining 
the molecular background of memory trials) due to the 
delayed timeframe of biochemical responses to environ-
mental stimuli. The role of ATP-dependent chromatin 
remodeling complexes in neurodevelopmental disorders, 
including schizophrenia, ASD, and various intellectual 
disabilities, was described.
Finally, we noted that the multidependency of envi-
ronmental factors and genetic vulnerability creates a vast 
range of therapeutic methods for both the prevention and 
management of different psychopathologies. We hypoth-
esized that research in this field can not only broaden our 
knowledge in the area of pathophysiology of mental dis-
eases but may also contribute to the development of swift 
diagnostic procedures as well as novel treatment targets.
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